Kinetic constants for binding of 3H-labeled morphine and naloxone were determined from Hill plot analyses and from experiments in which the concentration of tritiated drug was constant and that of nonlabeled drug varied. With brain slices, the binding of either drug exhibited strong positive cooperativity (Hill slope >3); this was not observed in brain homogenates. Thus, in slices the relationship between opiate binding site and ligand may be more relevant physiologically and pharmacologically.
Specific in vitro binding is a currently popular method used to quantify the interaction of receptor molecules with both endogenous and exogenous ligands such as drugs. Drug-receptor binding is frequently measured in crude tissue preparations by using varying concentrations of radiolabeled drug. The unbound material is removed by filtration or centrifugation, and binding to the receptor is assumed to be that portion of bound radioactive drug that can be displaced by excess amounts of nonlabeled drug. With this method, receptors for neurotransmitters (e.g., norepinephrine, dopamine, and serotonin) and the opiate analgesics and antagonists have been characterized as to their binding properties (1, 2) . In vitro binding experiments are valuable as tools for elucidating mechanisms of drug action and for screening new compounds (e.g., opiate-like drugs). However, with this technique, the nonsaturable, nonspecific binding increases linearly with the radiolabeled drug concentration so, at high drug concentrations which are necessary to show saturation and to determine maximum receptor binding accurately, receptor binding constitutes only a small portion of the total binding of radiolabeled ligand. We have developed a method for determining receptor binding parameters in vitro in which a fixed, low concentration of radiolabeled drug is used and the binding of labeled drug is assayed in the presence of increasing concentrations of nonlabeled drug. By using this analysis, the concentration of saturable opiate binding sites and their affinity for morphine and its antagonist, naloxone, were estimated. These studies have yielded data indicating that, in brain slices, the receptor sites for opiate agonists and antagonists exhibit positive cooperativity. This cooperativity is not observed in brain homogenates. Fig. 1 ) but will be sigmoidal if there is positive cooperativity among sites (n = 2 or 4, dashed and broken lines in Fig. 1) .
In the present studies the concentration of tritiated drug was fixed and the concentration of nonlabeled drug varied. Thus, the measured 3H-labeled drug binding by receptor is a fraction of the actual drug-receptor binding. In Fig. 2 ). This experimental design and analysis offers several advantages over the more conventional saturation experiment in which the binding of various concentrations of 3H-labeled drug is assayed. Foremost, the analysis of the data is not invalidated by cooperativity among sites, nor does it require prior accurate determination of Bmax. Additionally, the problem of linearly increasing nonsaturable binding, which can obscure receptor binding, is avoided and the use of radiolabeled drug is decreased, because a fixed, low concentration of radiolabeled drug is used. The values of Bmax, KD, and n were estimated directly from all data points by an iterative, nonlinear least squares regression analysis using Brown's method (4) to solve the normal equations or the Marquardt algorithm (5) for minimizing a sum of squares by nonlinear functions. A CDC 6500 computer was used in the analysis. 
RESULTS AND DISCUSSION
The initial increase in binding, characteristic of positive cooperativity, was seen in slice experiments for both 3Hjmorphine and 13Hjnaloxone binding (Fig. 3) .'This is in contrast to results obtained with homogenates (Fig. 4) , in which the data followed the pattern predicted for the absence of cooperativity. The parameters Bmax, KD, n, and C for slice data, determined by nonlinear regression analysis, are given in Table 1 . The index of cooperativity, n, is greater than 1 in the slice experiments for both the agonist morphine and antagonist naloxone. When the data were analyzed graphically by using a Hill plot (Fig. 3  inset) , n was slightly lower than these values but still >1 (2.6 for morphine, 3.4 for naloxone). Therefore, binding of one ligand molecule facilitates the binding of other molecules.
This cooperativity among binding sites was not observed in crude brain homogenates in the present experiments (n = 0.5 for morphine and 0.8 for naloxone) nor in earlier studies of naloxone and dihydromorphine binding to a particulate fraction of brain (6) . Pert and Snyder (7) reported data for 13H naloxone Binding parameters were determined by nonlinear least squares regression analysis of all data points. Bmax is the binding site concentration, KD (dissociation constant) is the concentration of drug at which half of the sites are bound, n is the number of interacting sites, and C is the nonsaturable binding. Binding was assayed in the absence of sodium. The values for C estimated by regression analysis and determined directly (in the presence of excess nonlabeled drug) are in good agreement.
binding to brain homogenates in which no evidence of cooperativity was seen (saturation and displacement curves both closely resembled the respective theoretical curve for n = 1). This was later confirmed by Simantov and Snyder (8) Simon and coworkers (9) found that, for [3Hlnaltrexone and [3Hletorphine binding, Scatchard plots were nonlinear and resembled the-case of n > 1; Simon (2) later reported n to be 1.5. These findings are interesting because they indicate that, if detectable at all, cooperativity is much less pronounced in preparations in which the cell membrane has been damaged. It is not surprising that interaction among sites is greater in a system in which the cell membrane is relatively unperturbed. Moreover, this cooperativity of binding could explain the relative steepness of morphine analgesia logarithmic dose-response curves.
The binding site concentration, Bmax, is greater for the antagonist naloxone (131 fmol/mg of protein) than for the agonist morphine (64 fmol/mg of protein); these values are in good agreement with those reported by other investigators using different drugs and tissue preparations (10, 11 
